13/Overall, we identify an interplay in the RCC TME between TLS & ZNF683+ SLAMF7+ exhausted CD8+ T cells that contribute to clinical outcomes with PD-1 blockade. This may help predict response to current therapies and inform strategies to overcome resistance to PD-1 ICI.
